Human infection with highly pathogenic H5N1 influenza virus

The Lancet

Volumn 371, Issue 9622, 2008, Pages 1464-1475

  Gambotto, Andrea ^a   Barratt Boyes, Simon M ^b   de Jong, Menno D ^c,d   Neumann, Gabriele ^e   Kawaoka, Yoshihiro ^e,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Center for Vaccine Research   (United States)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CYTOKINE; HEMAGGLUTININ; INFLUENZA VACCINE; MEASLES VACCINE; NONSTRUCTURAL PROTEIN 1; OSELTAMIVIR; PERAMIVIR; PLASMID DNA; PROTEIN PB 2; RIMANTADINE; SIALIDASE; VIRUS RNA; VIRUS VACCINE; ZANAMIVIR;

ADENOVIRUS; AGRICULTURAL WORKER; BACULOVIRUS; CLINICAL FEATURE; ECONOMIC ASPECT; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; MORTALITY; NONHUMAN; PANDEMIC; PATHOGENESIS; POULTRY; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS TRANSMISSION;

EID: 42949111564     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60627-3     Document Type: Review

References (167)